BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Galapagos 2021 results set stage for future growth

  Galapagos NV presents financial results 2021, reviews key events forthe company, and provides outlook for 2022.

  February 24, 2022

   · 

  21 min read
• Business

  Metacrine Announces Executive Leadership Changes

  Metacrine, Inc., a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases, announced that Ms. Trisha Millican has resigned her position as chief financial officer.

  February 24, 2022

   · 

  2 min read
• Genetown

  Cyclerion Announces CY6463 Clinical Pipeline and Corporate Updates

  Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, announced clinical development updates for CY6463, its lead program, and additional corporate progress.

  February 24, 2022

   · 

  8 min read
• Business

  Plus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights

  Plus Therapeutics, Inc. announced financial results for the fourth quarter and full year ended December 31, 2021, and provided an overview of recent business highlights.

  February 24, 2022

   · 

  10 min read
• Business

  Y-mAbs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Developments

  Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), today reported financial results for the fourth quarter and the full year ended December 31, 2021 and provided recent corporate highlights.

  February 24, 2022

   · 

  12 min read
• Business

  Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results

  Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer and other serious diseases, reported recent business progress and fourth-quarter and full-year 2021 financial results.

  February 24, 2022

   · 

  10 min read
• Business

  Curis Reports Fourth Quarter and Year End 2021 Financial Results

  Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported its financial results for the fourth quarter ended December 31, 2021.

  February 24, 2022

   · 

  16 min read
• Business

  Cryoport Reports Fourth Quarter and Full Year 2021 Results

  Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced financial results for the three months and year ended December 31, 2021.

  February 24, 2022

   · 

  23 min read
• Business

  AbCellera Reports Full Year 2021 Business Results

  AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, announced financial results for full year 2021.

  February 24, 2022

   · 

  15 min read
• Business

  Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights

  Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported fourth quarter and full year 2021 financial results and recent business highlights.

  February 24, 2022

   · 

  16 min read